» Articles » PMID: 22196955

Mutation Analysis of VCP in Familial and Sporadic Amyotrophic Lateral Sclerosis

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 2011 Dec 27
PMID 22196955
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive loss of motor neurons in the motor cortex, brain stem and spinal cord. Mutations in the valosin-containing protein gene (VCP) were recently described in ALS families. Some of these families included diagnoses of other clinical features including frontotemporal dementia, Paget's disease, inclusion body myopathy, Parkinsonism and limb weakness. We sought to determine the prevalence of VCP mutations in Australian familial (n = 131) and sporadic (n = 48) ALS cohorts diagnosed with classic ALS. No mutations were identified indicating that VCP mutations are not a common cause of classic ALS among Australian cases with predominantly European ancestry.

Citing Articles

Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases.

Chu S, Xie X, Payan C, Stochaj U Mol Neurodegener. 2023; 18(1):52.

PMID: 37545006 PMC: 10405438. DOI: 10.1186/s13024-023-00639-y.


Phenotype of VCP Mutations in Chinese Amyotrophic Lateral Sclerosis Patients.

Feng S, Lin H, Che C, Huang H, Liu C, Zou Z Front Neurol. 2022; 13:790082.

PMID: 35197922 PMC: 8858817. DOI: 10.3389/fneur.2022.790082.


VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes.

Martin-Doncel E, Rojas A, Cantarero L, Lazo P Sci Rep. 2019; 9(1):13381.

PMID: 31527692 PMC: 6746721. DOI: 10.1038/s41598-019-49821-7.


The genetics of amyotrophic lateral sclerosis: current insights.

Alsultan A, Waller R, Heath P, Kirby J Degener Neurol Neuromuscul Dis. 2018; 6:49-64.

PMID: 30050368 PMC: 6053097. DOI: 10.2147/DNND.S84956.


Myogenic differentiation of VCP disease-induced pluripotent stem cells: A novel platform for drug discovery.

Llewellyn K, Nalbandian A, Weiss L, Chang I, Yu H, Khatib B PLoS One. 2017; 12(6):e0176919.

PMID: 28575052 PMC: 5456028. DOI: 10.1371/journal.pone.0176919.